Sweden · Delayed Price · Currency is SEK Blueprint Medicines Statistics
Total Valuation
STO:ISOFOL has a market cap or net worth of SEK 247.51 million. The enterprise value is 165.41 million.
| Market Cap | 247.51M |
| Enterprise Value | 165.41M |
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025.
| Earnings Date | Aug 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ISOFOL has 281.11 million shares outstanding. The number of shares has decreased by -0.78% in one year.
| Current Share Class | 281.11M |
| Shares Outstanding | 281.11M |
| Shares Change (YoY) | -0.78% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.60% |
| Owned by Institutions (%) | 10.08% |
| Float | 128.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.85 |
| P/TBV Ratio | 3.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.40 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31
| Current Ratio | 4.31 |
| Quick Ratio | 4.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -50,427.00 |
Financial Efficiency
Return on equity (ROE) is -54.91% and return on invested capital (ROIC) is -35.56%.
| Return on Equity (ROE) | -54.91% |
| Return on Assets (ROA) | -29.11% |
| Return on Invested Capital (ROIC) | -35.56% |
| Return on Capital Employed (ROCE) | -77.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -8.11M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.81% in the last 52 weeks. The beta is 1.16, so STO:ISOFOL's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -68.81% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 41.43 |
| Average Volume (20 Days) | 2,040,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -40.00M |
| Operating Income | -50.43M |
| Pretax Income | -48.66M |
| Net Income | -48.66M |
| EBITDA | -50.42M |
| EBIT | -50.43M |
| Earnings Per Share (EPS) | -0.30 |
Balance Sheet
The company has 82.11 million in cash and n/a in debt, giving a net cash position of 82.11 million or 0.29 per share.
| Cash & Cash Equivalents | 82.11M |
| Total Debt | n/a |
| Net Cash | 82.11M |
| Net Cash Per Share | 0.29 |
| Equity (Book Value) | 64.29M |
| Book Value Per Share | 0.40 |
| Working Capital | 64.90M |
Cash Flow
| Operating Cash Flow | -45.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ISOFOL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.78% |
| Shareholder Yield | n/a |
| Earnings Yield | -19.66% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |